Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: Health-related quality of life (HRQL) and supportive care needs (SCN) of patients with gastroenteropancreatic neuroendocrine tumours (GEP-NET) remain understudied. Assessing and identifying the affected domains of HRQL and SCN of the patients with GEP-NET is part of the nursing practice and may contribute to adapt the nursing care.
Conference:
Presenting Author: Ho J
Authors: Ho J, Abdulle A, Messerli O, Eicher M, Schaefer N,
Keywords: gastroenteropancreatic neuroendocrine tumour, health related quality of life, quality of life, supportive care needs, unmet needs,
#3732 Urine 5-HIAA levels and quality-of-life in neuroendocrine neoplasia – Is there an association?
Introduction: Patients with neuroendocrine neoplasia (NEN) experience psychological distress related to secreting tumors. 5-hydroxyindoleacetic acid (5-HIAA) is a metabolite of serotonin, an important secretory product in carcinoid syndrome.
Conference:
Presenting Author:
Authors: Chaudhry R, White B, Chandrakumaran K, Vincent R, Srirajaskanthan R,
Keywords: neuroendocrine neoplasm, biomarker, 5-HIAA, Health-related quality of life (HRQL),
Introduction: Pancreatic neuroendocrine neoplasms (pNEN)
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author: Maurizi A
Authors: Maurizi A, Partelli S, Pezzilli R, Crippa S, Falconi M,
Keywords: pNEN, quality of life,
#45 Neuroendocrine tumor disease state and RAND-36 health-related quality of life scores
Introduction: Health-related quality of life (HRQL) can be disrupted in patients with malignancies.
Conference: 7th Annual ENETSConcerence (2010)
Presenting Author:
Authors: Phan A, Beaumont J, Liu Z, Choi S, Cella D,
Keywords: neuroendocrine tumor, health-related quality of life, carcinoid syndrome,
Introduction: Somatostatin analogues (SSAs) are used in patients with neuroendocrine tumors (NETs) for the management of carcinoid syndrome and/or delay of disease progression.
Conference: 7th Annual ENETSConcerence (2010)
Presenting Author:
Authors: Yao J, Beaumont J, Choi S, Cella D, Liu Z,
Keywords: neuroendocrine tumor, health-related quality of life, somatostatin analogue, carcinoid syndrome,